Drugmaker settles EpiPen antitrust litigation for $264M

Drugmaker settles EpiPen antitrust litigation for $264M

This post was originally published on this siteU.S. health care company Viatris, formerly known as Myland, on Monday announced it had agreed to pay $264 million to settle a class-action lawsuit over the pricing of EpiPens.The agreement, which must still be approved by the court, would seek…

Read more
AstraZeneca to take profits from Covid vaccine

AstraZeneca to take profits from Covid vaccine

This post was originally published on this siteThe drugs giant signs new deals, but poorer countries will continue to get the vaccine at cost price.

Read more